FDA Inspection 1196579 — Angelini Pharma Inc.
The FDA completed an inspection of Angelini Pharma Inc. on December 6, 2022 in Albany, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 6, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Albany, GA (United States)